We’re excited to introduce KinSight Kinome Profiling Services. Learn how profiling with a continuous assay and our detailed enzymological reports provide informative and actionable kinetic insights for your kinase drug discovery https://t.co/PNNFkicL9H
#kinomeprofiling#cancer
Context matters. That is why we created PhosphoSens-Lysate Assays –quantitative kinase activity insights where biology happens.
https://t.co/y82cqDT4Im
#KinaseInhibitor
Don’t miss Dr. Earl May's panel at the #CellSignalingSymposium!
Date/Time: Feb 19th | 2:55-4:25 PM
Location: Fairmont Hotel Vancouver
Topic: Continuous Enzymatic Assays for Drug Discovery
Connect with us to talk kinase kinetics & PhosphoSens® insights!
#CellSignaling
Join Dr. Earl May at the Cell Signaling Symposium on Feb 19 in Vancouver!
Time: 2:55–4:25 PM
Topic: A Continuous Enzymatic Assay Identifies and Characterizes Kinetic Modes of Action to Drive Drug Discovery
Discover the latest in cell signaling research!
https://t.co/FqKuZcelQX
Just dropped: PhosphoSens-Lysate Assays - real-time, direct fluorescence intensity measurement of kinase activity in crude cell lysates. Order MAPK1/ERK2 and MAPK3/ERK1 assays now, more targets coming soon!
https://t.co/bgfzh34mgI
#BiotechTools
Continuous fluorogenic assays = real-time, quantitative kinase & phosphatase activity insights.
Learn how this add & read technology is accelerating drug discovery at the Kinase Inhibitor Summit on February 11th at 10 am EST with Dr. Erik Schaefer.
#KinaseInhibitorSummit
Heading to the Kinase Inhibitor Summit? Don’t miss Dr. Erik Schaefer as he presents: Continuous Fluorogenic Assays for Kinase & Phosphatase Activity to Enable Drug Development
February 11th at 10 am EST | Boston, MA
#KinaseInhibitorSummit#DrugDiscovery
Target in focus: ERK1/2 PhosphoSens-Lysate Assays are here to accelerate
your kinase research. More targets coming soon!
https://t.co/ksv7iIsEKz
#BiotechBreakthrough
Announcing PhosphoSens-Lysate Assays: Measure kinase activity in real-time, directly in complex biological samples. Available now for MAPK1/ERK2 and MAPK3/ERK1!
https://t.co/y2Kd1LUCK8
#DrugDiscovery
Get more accurate kinase activity data with PhosphoSens®. Say goodbye to endpoint assays and hello to complete progress curves!
https://t.co/jHbO0OkNg5
#drugdiscovery#kinase
Maximize your resources! PhosphoSens® reduces the need for multiple assays, saving you time and money.
Learn more: https://t.co/K2XpwpSAUq
#drugdiscovery#technology#assay
Happy Holidays from Assay Quant. We’re celebrating with Kinome Trees! Transform complex kinase inhibition data into clear, publication-ready visualizations.
https://t.co/Lzt7ZYGOHt
Three steps to perfect (and festive) kinome trees:
1. Upload data
2. Choose theme
3. Generate & export
Happy Holidays from Assay Quant!
https://t.co/icgETKPDDK
It’s the perfect time of year to create, customize, and download high-resolution kinome trees for your next publication or presentation.
Get started for free: https://t.co/E4thn2X2rW
#SciComm
Endpoint assays do not reveal saturation kinetics. Saturation analysis can identify slow-binding or irreversible inhibition and quantify potency specific to that inhibitor type.
See what you could be missing: https://t.co/1MNte5N96a
#drugdiscovery#kinaseinhibitors
Are you able to recognize saturation in your progress curves?
Endpoint assays do not reveal saturation kinetics. With a continuous assay, you can identify and diagnose saturation in your progress curves.
See what you could be missing: https://t.co/b71nPCL3y5
Are you missing progress curve lags?
Lag times can expose issues and provide critical insights. Endpoint assays miss them and underestimated potency.
Learn how continuous assays expose lag time and provide critical insights for #drugdiscovery: https://t.co/2XOuubUgsh
What’s more festive than a Kinome Tree?! Zoom into specific kinase families for detailed analysis or view the complete kinome landscape.
https://t.co/azqUJJOtoD
#SciComm